Pharma Co. Asks For Stay To Appeal 'Orange Book' Delisting
Jazz Pharmaceuticals has asked a Delaware federal court to pause an order requiring it to ask the U.S. Food and Drug Administration to pull a patent that purportedly covers the distribution...To view the full article, register now.
Already a subscriber? Click here to view full article